Last reviewed · How we verify
NCT05869409
Physical Activity, Psychopathology, and Quality of Life in People With Psychotic or Affective Disorders
trial testing Physical activity and sedentary behavior education in Psychotic Disorders in 60 participants. Status unknown.
1 May 2025
Quick facts
| Lead sponsor | University of Social Sciences and Humanities, Warsaw |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 60 |
| Start date | 1 May 2022 |
| Primary completion | 1 May 2025 |
| Estimated completion | 1 December 2025 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Physical activity and sedentary behavior education
Conditions studied
- Psychotic Disorders — all drugs for Psychotic Disorders →
- Affective Disorder — all drugs for Affective Disorder →
Sponsor
University of Social Sciences and Humanities, Warsaw
Who can join
18 and older, any sex, with Psychotic Disorders or Affective Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This longitudinal observational study tests the associations between physical activity, health-related quality of life, and psychopathology symptoms among people diagnosed with schizophrenia or diagnosed with affective disorders. It was assumed that higher levels of physical activity at baseline will be related to better quality of life (across physical, social, and psychological domains), and lower psychopathology symptoms (positive and negative symptoms of psychosis, general psychopathology, and depression severity) at 6-week follow-up measurement. Adult participants with a diagnosis of a psychotic disorder or a diagnosis of an affective disorder will be enrolled.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05869409
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Psychotic Disorders
Currently open trials in the same condition.
- NCT07460453 — Racial Disparities in the Expression of Paranoia · NA · recruiting
- NCT06758414 — CBT-CP for Veterans With SMI · NA · recruiting
- NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis · NA · recruiting
- NCT07360665 — Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin · NA · recruiting
- NCT06993662 — The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective. · Phase 1 · active not recruiting
Other University of Social Sciences and Humanities, Warsaw trials
Trials by the same sponsor.
- NCT06944990 — Meta Self-efficacy Internet Intervention to Improve Work Self-efficacy and Occupational Well-being in Young Employees · NA · not yet recruiting
- NCT07429617 — Effects of Darkness Retreat: a Pilot Study · NA · recruiting
- NCT07189715 — Optimization of Imagery Rescripting Research Using Generative Artificial Intelligence · NA · recruiting
- NCT06570694 — RCT Protocol for 'OverThinking': A Mobile EMI for Reducing Experiential Avoidance · NA · not yet recruiting
- NCT07405632 — The Impact of Supplementation With Hericium Erinaceus (Lion's Mane) Extract on Cognitive Functioning · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05869409 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Social Sciences and Humanities, Warsaw
- Last refreshed: 22 May 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05869409.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing